Navigation Links
Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
Date:1/3/2008

SAN DIEGO, Jan. 2 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the 26th Annual JPMorgan Healthcare Conference on Wednesday, January 9, 2008 at approximately 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time). The presentation is scheduled to be webcast live and may be accessed through a link on the investor information section of Gen-Probe's website at http://www.gen-probe.com. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended September 30, 2007, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
2. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
3. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
4. Webcast Alert: Kaiser Permanente Residency Program Open House
5. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
6. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
7. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
8. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
9. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
10. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 23, 2017 , ... Despite its pervasiveness, many ... reviews available that integrate basic science with clinical practice. Now, however, a timely review ... providing clinicians with insight into the etiology of NeuP and educating preclinical scientists on ...
(Date:6/22/2017)... (PRWEB) , ... June 22, 2017 , ... A June ... Rittenberg to a correspondent concerned about an apparent lack of oral hygiene by an ... specializes in geriatrics and dementia-related matters, suggests a number of steps, including scheduling a ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... CHRISTUS Health, a Texas-based health system, will present how predictive analytics drive reimbursement ... HFMA ANI meeting in Orlando, June 25-28. , “The traditional approach to ...
(Date:6/20/2017)... Gainesville, FL (PRWEB) , ... June 20, 2017 ... ... interactive health science curriculum , is pleased to announce a new online ... The accredited online course provides practical insights and evidence-based strategies for achieving optimal ...
(Date:6/20/2017)... ... ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among his ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency Plan ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Infusion Group, a brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has ... location. The Iowa facility ... cleanroom—the standard needed to compound intravenous (IV) nutrition formulations. A cleanroom ... "Our new cleanroom will allow us ... Iowa patients," said Phil Rielly , Diplomat ...
(Date:6/1/2017)... 1, 2017 Nutriceutical Holdings (NH), parent company ... (VRS), and KD Pharma Group have decided to join ... KD Pharma Group. KD Pharma Group will become the ... acquire the entire company. "We believe we ... committed to growing the NH companies by providing us ...
(Date:5/26/2017)...  Endo International plc (NASDAQ: ENDP ) announced ... represent the Company in a fireside chat at Goldman Sachs, ... 13, 2017 at 10:40 a.m. PT / 1:40 p.m. ET. ... Rancho Palos Verdes, CA. A ... available on the Company,s website at http://www.endo.com/investors/overview . Participants ...
Breaking Medicine Technology: